James Lightwood, PhD

Title(s)Associate Professor, Clinical Pharmacy
SchoolSchool of Pharmacy
Address521 Parnassus Avenue, #3rd Fl
San Francisco CA 94117
ORCID ORCID Icon0000-0002-4720-3329 Additional info
vCardDownload vCard

    Collapse Overview 

    Collapse ORNG Applications 
    Collapse Academic Senate

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. The association of current exclusive e-cigarette use and dual use of e-cigarettes and cigarettes with psychological distress among U.S. adults. Prev Med Rep. 2023 Dec; 36:102425. Wang Y, Sung HY, Lea Watkins S, Lightwood J, Yao T, Max W. PMID: 37810268; PMCID: PMC10556823.
      View in: PubMed   Mentions: 1  
    2. Smoking and healthcare expenditure reductions associated with the California Tobacco Control Program, 1989 to 2019: A predictive validation. PLoS One. 2023; 18(3):e0263579. Lightwood JM, Anderson S, Glantz SA. PMID: 36928830; PMCID: PMC10019627.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    3. Healthcare utilisation and expenditures attributable to current e-cigarette use among US adults. Tob Control. 2023 11; 32(6):723-728. Wang Y, Sung HY, Lightwood J, Yao T, Max WB. PMID: 35606163.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    4. Abstract P250: The Impact of Recreational Cannabis Legalization on All-cause Hospitalizations and Acute Cardiovascular Event Hospitalizations in Colorado. Circulation. 2020 Mar 3; 141(Suppl_1). Jeffers JA, Lightwood LJ, Keyhani KS. .
      View in: Publisher Site   Mentions:
    5. Predictive validation and forecasts of short-term changes in healthcare expenditure associated with changes in smoking behavior in the United States. PLoS One. 2020; 15(1):e0227493. Lightwood J, Anderson S, Glantz SA. PMID: 31945079; PMCID: PMC6964879.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    6. Estimating the long-run relationship between state cigarette taxes and county life expectancy. Tob Control. 2020 01; 29(1):81-88. Baum A, Aguilar-Gomez S, Lightwood J, Bruzelius E, Glantz SA, Basu S. PMID: 30705247; PMCID: PMC6669122.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    7. Healthcare Costs of Secondhand Smoke Exposure at Home for U.S. Children. Am J Prev Med. 2019 02; 56(2):281-287. Yao T, Sung HY, Wang Y, Lightwood J, Max W. PMID: 30553690; PMCID: PMC6340755.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansPHPublic Health
    8. Modelling the impact of a new tobacco product: review of Philip Morris International's Population Health Impact Model as applied to the IQOS heated tobacco product. Tob Control. 2018 11; 27(Suppl 1):s82-s86. Max WB, Sung HY, Lightwood J, Wang Y, Yao T. PMID: 30275170; PMCID: PMC6240026.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    9. Health Care Utilization and Expenditures Attributable to Smokeless Tobacco Use Among US Adults. Nicotine Tob Res. 2018 09 25; 20(11):1359-1368. Wang Y, Sung HY, Lightwood J, Chaffee BW, Yao T, Max W. PMID: 29059335; PMCID: PMC6154986.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    10. Polytobacco Use and Nicotine Dependence Symptoms Among US Adults, 2012-2014. Nicotine Tob Res. 2018 08 14; 20(suppl_1):S88-S98. Sung HY, Wang Y, Yao T, Lightwood J, Max W. PMID: 30125019; PMCID: PMC6093419.
      View in: PubMed   Mentions: 66     Fields:    Translation:Humans
    11. Infrequent and Frequent Nondaily Smokers and Daily Smokers: Their Characteristics and Other Tobacco Use Patterns. Nicotine Tob Res. 2018 05 03; 20(6):741-748. Wang Y, Sung HY, Yao T, Lightwood J, Max W. PMID: 28186549; PMCID: PMC5934666.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    12. Health Care Utilization and Expenditures Attributable to Cigar Smoking Among US Adults, 2000-2015. Public Health Rep. 2018 May/Jun; 133(3):329-337. Wang Y, Sung HY, Yao T, Lightwood J, Max W. PMID: 29688130; PMCID: PMC5958399.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    13. Healthcare costs attributable to secondhand smoke exposure at home for U.S. adults. Tobacco Induced Diseases. 2018 Mar 1; 16(1). Yao YT, Sung SH, Wang WY, Lightwood LJ, Max MW. .
      View in: Publisher Site   Mentions:
    14. Healthcare costs attributable to secondhand smoke exposure at home for U.S. adults. Prev Med. 2018 03; 108:41-46. Yao T, Sung HY, Wang Y, Lightwood J, Max W. PMID: 29288781; PMCID: PMC5829047.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansPHPublic Health
    15. Relationship between spending on electronic cigarettes, 30-day use, and disease symptoms among current adult cigarette smokers in the U.S. PLoS One. 2017; 12(11):e0187399. Yao T, Max W, Sung HY, Glantz SA, Goldberg RL, Wang JB, Wang Y, Lightwood J, Cataldo J. PMID: 29112988; PMCID: PMC5675454.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    16. PHP10 Interrupted Time Series Analysis Evaluating The Impact of A Pro-Generic Policy on Drug Pricing and Utilization In Argentina. Value in Health. 2017 Oct 1; 20(9):a899. Wilson WL, Yi YE, Lightwood LJ, Lee LB, Garay GU. .
      View in: Publisher Site   Mentions:
    17. Factors associated with short-term transitions of non-daily smokers: socio-demographic characteristics and other tobacco product use. Addiction. 2017 May; 112(5):864-872. Wang Y, Sung HY, Yao T, Lightwood J, Max W. PMID: 27886652; PMCID: PMC5382088.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    18. Smoking Behavior and Healthcare Expenditure in the United States, 1992-2009: Panel Data Estimates. PLoS Med. 2016 05; 13(5):e1002020. Lightwood J, Glantz SA. PMID: 27163933; PMCID: PMC4862673.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansPHPublic Health
    19. Sociodemographic Differences Among U.S. Children and Adults Exposed to Secondhand Smoke at Home: National Health Interview Surveys 2000 and 2010. Public Health Rep. 2016 Mar-Apr; 131(2):357-66. Yao T, Sung HY, Wang Y, Lightwood J, Max W. PMID: 26957671; PMCID: PMC4765985.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansPHPublic Health
    20. Improved Label and Liver Warning for Nonprescription Acetaminophen Products. Ther Innov Regul Sci. 2015 Nov; 49(6):890-897. Soller RW, Ho T, Lightwood JM. PMID: 30222378.
      View in: PubMed   Mentions: 1     Fields:    
    21. Polytobacco Use of Cigarettes, Cigars, Chewing Tobacco, and Snuff Among US Adults. Nicotine Tob Res. 2016 May; 18(5):817-26. Sung HY, Wang Y, Yao T, Lightwood J, Max W. PMID: 26136525; PMCID: PMC5896811.
      View in: PubMed   Mentions: 49     Fields:    Translation:Humans
    22. Health benefits of reducing sugar-sweetened beverage intake in high risk populations of California: results from the cardiovascular disease (CVD) policy model. PLoS One. 2013; 8(12):e81723. Mekonnen TA, Odden MC, Coxson PG, Guzman D, Lightwood J, Wang YC, Bibbins-Domingo K. PMID: 24349119; PMCID: PMC3859539.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    23. PHP5 Argentina’s Generic Drug Law: Was It Successful?. Value in Health. 2013 Nov 1; 16(7):a672. Lee LB, Garay GO, Goldhaber-Fiebert GJ, Tang TJ, Lightwood LJ, Wilson WL. .
      View in: Publisher Site   Mentions:
    24. Pharmacy students teaching prescribers strategies to lower prescription drug costs for underserved patients. J Manag Care Pharm. 2013 Sep; 19(7):534-41. Stebbins MR, Frear ME, Cutler TW, Lightwood JM, Fingado AR, Lai CJ, Lipton HL. PMID: 23964614; PMCID: PMC10437620.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    25. The effect of the California tobacco control program on smoking prevalence, cigarette consumption, and healthcare costs: 1989-2008. PLoS One. 2013; 8(2):e47145. Lightwood J, Glantz SA. PMID: 23418411; PMCID: PMC3572143.
      View in: PubMed   Mentions: 38     Fields:    Translation:HumansPHPublic Health
    26. Corrigendum: Improvement of the Drug Allergy Alert for Nonprescription NSAIDs. Therapeutic Innovation & Regulatory Science. 2012 Sep 1; 46(5):627-627. Soller SR, Shaheen SC, Yen YJ, Rose RJ, Lightwood LJ. .
      View in: Publisher Site   Mentions:
    27. Improvement of the Drug Allergy Alert for Nonprescription NSAIDs. Therapeutic Innovation & Regulatory Science. 2012 May 1; 46(3):336-343. Soller SR, Shaheen SC, Yen YJ, Rose RJ, Lightwood LJ. .
      View in: Publisher Site   Mentions:
    28. The impact of changes in tobacco control funding on healthcare expenditures in California, 2012-2016. Tob Control. 2013 May; 22(e1):e10-5. Max W, Sung HY, Lightwood J. PMID: 22253003.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    29. Association between smokefree laws and voluntary smokefree-home rules. Am J Prev Med. 2011 Dec; 41(6):566-72. Cheng KW, Glantz SA, Lightwood JM. PMID: 22099232; PMCID: PMC3222862.
      View in: PubMed   Mentions: 72     Fields:    Translation:HumansPHPublic Health
    30. Evaluation of value-based insurance design with a large retail employer. Am J Manag Care. 2011 Oct; 17(10):682-90. Kim YA, Loucks A, Yokoyama G, Lightwood J, Rascate K, Serxner SA. PMID: 22106461.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    31. The impact of the aging population on coronary heart disease in the United States. Am J Med. 2011 Sep; 124(9):827-33.e5. Odden MC, Coxson PG, Moran A, Lightwood JM, Goldman L, Bibbins-Domingo K. PMID: 21722862; PMCID: PMC3159777.
      View in: PubMed   Mentions: 91     Fields:    Translation:Humans
    32. Effect of the Arizona tobacco control program on cigarette consumption and healthcare expenditures. Soc Sci Med. 2011 Jan; 72(2):166-72. Lightwood J, Glantz S. PMID: 21168248; PMCID: PMC3603372.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    33. Projected Effect of Dietary Salt Reductions on Future Cardiovascular Disease. Obstetrical & Gynecological Survey. 2010 Jul 1; 65(7):441-442. Bibbins-Domingo BK, Chertow CG, Coxson CP, Moran MA, Lightwood LJ, Pletcher PM, Goldman GL. .
      View in: Publisher Site   Mentions:
    34. Projected effect of dietary salt reductions on future cardiovascular disease. N Engl J Med. 2010 Feb 18; 362(7):590-9. Bibbins-Domingo K, Chertow GM, Coxson PG, Moran A, Lightwood JM, Pletcher MJ, Goldman L. PMID: 20089957; PMCID: PMC3066566.
      View in: PubMed   Mentions: 442     Fields:    Translation:Humans
    35. Black box warning contraindicated comedications: concordance among three major drug interaction screening programs. Ann Pharmacother. 2010 Jan; 44(1):28-34. Wang LM, Wong M, Lightwood JM, Cheng CM. PMID: 20040698.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansPHPublic Health
    36. Forecasting the future economic burden of current adolescent overweight: an estimate of the coronary heart disease policy model. Am J Public Health. 2009 Dec; 99(12):2230-7. Lightwood J, Bibbins-Domingo K, Coxson P, Wang YC, Williams L, Goldman L. PMID: 19833999; PMCID: PMC2775763.
      View in: PubMed   Mentions: 41     Fields:    Translation:Humans
    37. Declines in acute myocardial infarction after smoke-free laws and individual risk attributable to secondhand smoke. Circulation. 2009 Oct 06; 120(14):1373-9. Lightwood JM, Glantz SA. PMID: 19770392; PMCID: PMC2967202.
      View in: PubMed   Mentions: 73     Fields:    Translation:HumansPHPublic Health
    38. Comparing impact and cost-effectiveness of primary prevention strategies for lipid-lowering. Ann Intern Med. 2009 Feb 17; 150(4):243-54. Pletcher MJ, Lazar L, Bibbins-Domingo K, Moran A, Rodondi N, Coxson P, Lightwood J, Williams L, Goldman L. PMID: 19221376.
      View in: PubMed   Mentions: 76     Fields:    Translation:HumansPHPublic Health
    39. Coronary heart disease attributable to passive smoking: CHD Policy Model. Am J Prev Med. 2009 Jan; 36(1):13-20. Lightwood JM, Coxson PG, Bibbins-Domingo K, Williams LW, Goldman L. PMID: 19095162; PMCID: PMC3940697.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansPHPublic Health
    40. Effect of the California tobacco control program on personal health care expenditures. PLoS Med. 2008 Aug 26; 5(8):e178. Lightwood JM, Dinno A, Glantz SA. PMID: 18752344; PMCID: PMC2522256.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    41. Adolescent overweight and future adult coronary heart disease. N Engl J Med. 2007 Dec 06; 357(23):2371-9. Bibbins-Domingo K, Coxson P, Pletcher MJ, Lightwood J, Goldman L. PMID: 18057339.
      View in: PubMed   Mentions: 158     Fields:    Translation:Humans
    42. Comparison of the packaging and labeling of Target ClearRx with conventional prescription drug packaging and labeling. J Am Pharm Assoc (2003). 2007 Jul-Aug; 47(4):484-90. Soller RW, Lightwood JM. PMID: 17616494.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    43. Cost-effectiveness of bupropion, nortriptyline, and psychological intervention in smoking cessation. J Behav Health Serv Res. 2005 Oct-Dec; 32(4):381-92. Hall SM, Lightwood JM, Humfleet GL, Bostrom A, Reus VI, Muñoz R. PMID: 16215448.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    44. Cost-Effectiveness of Bupropion, Nortriptyline, and Psychological Intervention in Smoking Cessation. The Journal of Behavioral Health Services & Research. 2005 Oct 1; 32(4):381???392. Hall HS, Lightwood LJ, Humfleet HG, Bostrom BA, Reus RV, Mu??oz MR. .
      View in: Publisher Site   Mentions:
    45. The economics of smoking and cardiovascular disease. Prog Cardiovasc Dis. 2003 Jul-Aug; 46(1):39-78. Lightwood J. PMID: 12920700.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    46. Cost Optimization in the SIS Model of Infectious Disease with Treatment. Topics in Economic Analysis & Policy. 2002 Apr 24; 2(1). Goldman GS, Lightwood LJ. .
      View in: Publisher Site   Mentions:
    47. Smoking cessation in heart failure: it is never too late. J Am Coll Cardiol. 2001 May; 37(6):1683-4. Lightwood J, Fleischmann KE, Glantz SA. PMID: 11345384.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    48. Model of estimated rates of colorectal cancer from polyp growth by year of surveillance. J Med Screen. 2001; 8(4):187-96. Wilson LS, Lightwood J. PMID: 11743035.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansPHPublic Health
    49. International implications of the United States ‘global settlement’ of tobacco litigation. Tobacco: The Growing Epidemic. 2000 Jan 1; 826-829. Fox FB, Lightwood LJ, Glantz GS. .
      View in: Publisher Site   Mentions:
    50. Short-term health and economic benefits of smoking cessation: low birth weight. Pediatrics. 1999 Dec; 104(6):1312-20. Lightwood JM, Phibbs CS, Glantz SA. PMID: 10585982.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    51. Pancreatic cancer: total costs and utilization of health services. J Surg Oncol. 1999 Jul; 71(3):171-81. Wilson LS, Lightwood JM. PMID: 10404134.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    52. Short-term economic and health benefits of smoking cessation: myocardial infarction and stroke. Circulation. 1997 Aug 19; 96(4):1089-96. Lightwood JM, Glantz SA. PMID: 9286934.
      View in: PubMed   Mentions: 87     Fields:    Translation:Humans
    53. Tobacco litigation. Issues for public health and public policy. JAMA. 1997 Mar 05; 277(9):751-3. Glantz SA, Fox BJ, Lightwood JM. PMID: 9042849.
      View in: PubMed   Mentions: 3     Fields:    Translation:PHPublic Health
    54. Tobacco Litigation: Issues for Public Health and Public Policy. JAMA. 1997 Mar 5; 277(9):751-753. Glantz GS, Fox FB, Lightwood LJ. .
      View in: Publisher Site   Mentions:
    James's Networks
    Concepts (182)
    Derived automatically from this person's publications.
    Co-Authors (21)
    People in Profiles who have published with this person.
    Similar People (60)
    People who share similar concepts with this person.
    Same Department
    Search Department